Epoch 50 - How Biotech Companies That Lose Money are Worth Billions

Perspective Sets Valuation, Market Comps, IPO vs. M&A

Welcome to the 61 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 921 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:

Hello Avatar! Welcome back for another week of biotech analysis.  This week was a big one on the business side of biotech. The massive deal between …